Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.38 USD | -0.26% | +2.38% | +3.05% |
07-11 | CAC40: maintains gains after reassuring US inflation figures | CF |
07-11 | CAC40: rise without volume, W-Street at its zenith but falls back | CF |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.05% | 10.04B | - | ||
+55.35% | 815B | C+ | ||
+32.75% | 597B | B | ||
-0.10% | 377B | C+ | ||
+15.47% | 319B | B- | ||
+13.10% | 310B | C+ | ||
+16.51% | 247B | B+ | ||
+15.02% | 228B | B- | ||
+16.54% | 180B | C+ | ||
+4.31% | 170B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- IPN Stock
- IPSEY Stock
- Ratings Ipsen S.A.